Emily M. Leproust

CIK 1753655 · Chief Executive Officer · last filed 2026-10-07

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$96.92M

Companies

Total Filings

231

Lifetime Open-Market Net

-$174.96M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

TWST price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address

C/O TWIST BIOSCIENCE CORPORATION
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO, CA 94158

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
TWST	Chief Executive Officer	596,549	$159.85	$95.36M	-$174.96M	155	2026-10-07
WGS	Director	24,852	$62.74	$1.56M	$0	1	2026-06-23
GeneDx Holdings Corp. (WGSWW) Delisted	Director	21,276	$0.00	$4	$0	5	2025-06-23
GeneDx Holdings Corp. (SMFRW) Delisted	Director	37,836	$0.02	$908	$0	5	2022-05-12

Recent Filings · Page 18 of 24

231 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2022-04-26	TWST	Tax (F)	−923	-$31.6K	EDGAR
2022-04-05	TWST	Tax (F)	−1,108	-$58.6K	EDGAR
2022-02-23	TWST	Tax (F)	−2,837	-$151.0K	EDGAR
2022-01-26	TWST	Tax (F)	−1,008	-$56.3K	EDGAR
2022-01-20	TWST	Mixed	−579	-$59.5K	EDGAR
2022-01-04	TWST	Mixed	+22,181	$114.5K	EDGAR
2021-12-29	TWST	Mixed	+10,395	-$428.8K	EDGAR
2021-12-10	TWST	Mixed	—	-$553.8K	EDGAR
2021-11-23	TWST	Tax (F)	−2,829	-$312.9K	EDGAR
2021-11-17	TWST	Mixed	—	-$1.14M	EDGAR

Showing 171–180 of 231

Prev Page 18 of 24 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.